Phase 2Active, not recruitingAge-related condition
A Study in Subjects With Neurogenic Orthostatic Hypotension
A Single-Blind Dose-Ranging Study in Subjects With Neurogenic Orthostatic Hypotension to Evaluate the Effect of CST-3056 on Symptoms and Signs of Orthostatic Hypotension
- Sponsor
- CuraSen Therapeutics, Inc. (Industry)
- Enrolment
- 12 enrolled
- Conditions
- Neurogenic Orthostatic Hypotension
- Interventions
- CST-3056; Placebo
- Ages
- adults, older adults
- Registry
- NCT07089043
Full record on ClinicalTrials.gov
From the registry
This is a study to evaluate the effects of CST-3056 on orthostatic symptoms and signs in subjects with neurogenic orthostatic hypotension (nOH).
Primary outcomes
- Change from Baseline in Standing Systolic Blood Pressure
History
Study completion
Last registry update
Primary completion
Started
Registered